Business Standard

Monday, December 23, 2024 | 05:12 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

China vaccine maker applies for public use of Covid-19 shot: Report

The vaccine race has taken on vital importance as countries look to more definitively re-open their economies and stem a pandemic that has sickened more than 59 million.

Coronavirus, vaccine, covid, drugs, clinical trials
Premium

Inoculations are seen as the best hope as a fresh wave of infections is forcing nations to reintroduce lockdowns and other restrictions.

Bloomberg
A leading Chinese vaccine developer has applied for authorization to bring its Covid-19 shot to the market, seeking to get a jump on Western rivals as the race for a working inoculation against the virus enters the final stretch.
 
China National Biotec Group Co. has submitted an application to Chinese regulators, reported state media Xinhua Finance on Wednesday, citing parent company Sinopharm’s vice general manager Shi Shengyi. The application likely includes interim data from the company’s Phase III human testing conducted in the Middle East and South America.
 
Stocks related to Sinopharm Group, including its Hong Kong unit,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in